PMID: 2524188Apr 15, 1989Paper

Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors

The Biochemical Journal
M WalkerR Jefferis

Abstract

Aglycosylated human IgG1 and IgG3 monoclonal anti-D (Rh) and human IgG1 and IgG3 chimaeric anti-5-iodo-4-hydroxy-3-nitrophenacetyl (anti-NIP) monoclonal antibodies produced in the presence of tunicamycin have been compared with the native glycosylated proteins with respect to recognition by human Fc gamma RI and/or Fc gamma RII receptors on U937, Daudi or K562 cells. Human red cells sensitized with glycosylated IgG3 form rosettes via Fc gamma RI with 60% of U937 cells. Inhibition of rosette formation required greater than 35-fold concentrated more aglycosylated than glycosylated human monoclonal anti-D (Rh) antibody. Unlabelled polyclonal human IgG and glycosylated monoclonal IgG1 and anti-D (Rh) antibody inhibited the binding of 125I-labelled monomeric human IgG binding by U937 Fc gamma RI at concentrations greater than 50-fold lower than the aglycosylated monoclonal IgG1 anti-D (Rh) (K50 approximately 3 x 10(-9) M and approximately 6 x 10(-7) M respectively). Similar results were obtained using glycosylated and aglycosylated monoclonal human IgG1 or IgG3 chimaeric anti-NIP antibody-sensitized red cells rosetting with Fc gamma RI-/Fc gamma RII+ Daudi and K562 cells. Rosette formation could be inhibited by the glycosylated form...Continue Reading

Citations

Oct 20, 2006·Expert Opinion on Biological Therapy·Mitsuo SatohKenya Shitara
Feb 27, 2016·Signal Transduction and Targeted Therapy·Sasha BogdanovichJayakrishna Ambati
Nov 10, 2009·Current Opinion in Biotechnology·William R Strohl
Jan 28, 2016·Journal of Proteome Research·L Renee RuhaakGary Leiserowitz
Dec 1, 1991·Baillière's Clinical Haematology·T W HuizingaA E von dem Borne
May 10, 2015·Applied Microbiology and Biotechnology·Dezhong WangXiaokun Li
Apr 5, 2002·Fish & Shellfish Immunology·Bergljót MagnadóttirPauline M Rudd
Apr 28, 2010·PloS One·Conrad En Zuo ChanBrendon John Hanson
Jun 3, 2000·Annual Review of Immunology·V Ghetie, E S Ward
Jan 1, 1996·Annual Review of Cell and Developmental Biology·M Raghavan, P J Bjorkman
Oct 4, 2011·Vaccine·Jamie Heimburg-MolinaroKate Rittenhouse-Olson
Jun 1, 1991·Transfusion Medicine·K ThompsonM Melamed
Jan 1, 2010·Biotechnology & Genetic Engineering Reviews·Roy Jefferis
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Stephen L SazinskyK Dane Wittrup
Jan 1, 1993·International Reviews of Immunology·S U ShinS L Morrison
Oct 31, 2017·The Journal of Clinical Investigation·Rebecca T VeenhuisAndrea L Cox
Jul 1, 1997·Nature Biotechnology·P HolligerG Winter
Sep 28, 2005·Biotechnology and Bioengineering·Dale WarnockRobert J Bayer
Dec 1, 1992·Immunological Reviews·J R Adair
Jan 1, 1992·Folia Microbiologica·L TuckováV Vĕtvicka
Nov 1, 1995·British Journal of Haematology·A G HadleyR J Sokol
Jan 6, 2010·Current Opinion in HIV and AIDS·Georgia D Tomaras, Barton F Haynes
Mar 23, 2012·Seminars in Immunopathology·Sybille BöhmFalk Nimmerjahn
Mar 13, 2012·Journal of Molecular Recognition : JMR·Thomas C NessporRandall J Brezski
Jul 16, 2013·Gut Microbes·Cara L CookeJay V Solnick
Sep 4, 2019·The Journal of Clinical Investigation·Taia T Wang, Jeffrey V Ravetch

❮ Previous
Next ❯